Identification | Back Directory | [Name]
4'-Demethylepipodophyllotoxin | [CAS]
6559-91-7 | [Synonyms]
4'-DMEP Podophyllotoxin Derivate 1 Demethylpodophyllotoxin, 4'- 4-DEMETHYL EPIPODOPHYLLOTOXIN 4'-DEMETHYLEPIPODOPHYLLOTOXIN 4 -DEMETHYL EIPODOPHYLLOTOXIN 4'-DEMETHYLEPIPODOPHYLLOTOXINE 4'-O-deMethylepipodophyllotoxin 4 -DEMETHYL EIPODOPHYLLOTOXIN 95% 4'-Demethylepipodophyllotoxin ,98% 4-DeMethyl Epipodophyllotoxin(DMEP) 4-Domethylpodophyllotoxin, 4'-demethyl-epi-Podophyllotoxin oxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-,(5r-(5-alpha,5a-beta,8a-alpha,9-beta)) (5R)-5β-(3,5-Dimethoxy-4-hydroxyphenyl)-9α-hydroxy-5,5aα,6,8,8aβ,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxole-6-one (5R)-5,8,8aβ,9-Tetrahydro-9α-hydroxy-5β-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aαH)-one (5R,5aα,8aβ)-5,8,8a,9-Tetrahydro-5β-(4-hydroxy-3,5-dimethoxyphenyl)-9α-hydroxyfuro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one (5R,5aR,8aR,9S)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one,5,8,8a,9-tetrahydro-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-,(5R,5aR,8aR,9S)- (5R)-5β-(3,5-Dimethoxy-4-hydroxyphenyl)-7α-(hydroxymethyl)-8α-hydroxy-5,6,7,8-tetrahydronaphtho[2,3-d]-1,3-dioxole-6β-carboxylic acid 6,7-lactone | [EINECS(EC#)]
2017-001-1 | [Molecular Formula]
C21H20O8 | [MDL Number]
MFCD00189421 | [MOL File]
6559-91-7.mol | [Molecular Weight]
400.38 |
Chemical Properties | Back Directory | [Appearance]
Off-White Solid | [Melting point ]
246-248°C | [Boiling point ]
626.5±55.0 °C(Predicted) | [density ]
1.446±0.06 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
9.94±0.40(Predicted) | [color ]
White to Off-White | [InChIKey]
YVCVYCSAAZQOJI-JHQYFNNDSA-N | [SMILES]
O1C2=CC3=C(C=C2OC1)[C@@H](C1=CC(OC)=C(O)C(OC)=C1)[C@@]1([H])C(=O)OC[C@]1([H])[C@@H]3O |
Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Uses]
A potent inhibitor of microtubule assembly | [Definition]
ChEBI: An organic heterotetracyclic compound that is the 9- epimer of 4'-demethylpodophyllotoxin. | [Synthesis]
(5R,5aR,8aR,9R)-9-Hydroxy-5-(3,4,5-trimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one (onychocercazylidene, 2.1 g, 5.0 mmol) was used as a raw material and dissolved in anhydrous dichloromethane. Sodium iodide (2.3 g, 15.0 mmol) was added to this solution and stirred for 5 min. The reaction mixture was cooled to 0°C (ice-water bath) and methanesulfonic acid (1.48 mL, 15.0 mmol) was added slowly dropwise, after which stirring was continued and gradually brought to room temperature. The reaction was continued at room temperature for 5 hours, during which time nitrogen was introduced to remove the HI gas generated from the reaction. After completion of the reaction, the solvent was removed by concentration under reduced pressure. The crude product was dissolved in a solvent mixture of acetone-water (25 mL-25 mL), barium carbonate (2.0 g, 10.0 mmol) was added, and the reaction was carried out at 40 °C for 30 min. The reaction solution was diluted with dichloromethane (100 mL), poured into 500 mL of 10% aqueous sodium thiosulfate solution and extracted with dichloromethane. The organic phases were combined, dried with anhydrous sodium sulfate and concentrated under reduced pressure to obtain the crude product. The crude product was purified by silica gel column chromatography (eluent: chloroform:methanol=92:8) to afford the target product (5R,5aR,8aR,9S)-9-hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxolan-6(8H)-one ( VII, 1.8g, 90% yield), as white solid. | [in vivo]
4'-Demethylepipodophyllotoxin (1 μg/mL, 200 μL, topical application, 24 weeks) reduces the tumor incidence, tumor volume, and the conversion efficiency of papillomas to squamous cell carcinomas in DMBA/TPA-induced mouse skin carcinogenesis model[1].
| [References]
[1] Synthetic Communications, 2012, vol. 42, # 18, p. 2780 - 2789 [2] Patent: CN104098594, 2016, B. Location in patent: Paragraph 0040-0041 [3] European Journal of Medicinal Chemistry, 2011, vol. 46, # 3, p. 901 - 906 [4] Journal of Medicinal Chemistry, 2015, vol. 58, # 11, p. 4851 - 4856 [5] Journal of Medicinal Chemistry, 1998, vol. 41, # 23, p. 4475 - 4485 |
|
|